Stoke Therapeutics

0 followers
‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Employees

51-200

Links


Org chart

Edward M. Kaye
CEO & Director
Collapse
Dawn Kalmar
Chief Of Corporate Affairs & Strategic Partnerships
Barry S. Ticho
Chief Medical Officer
Jonathan Allan
General Counsel
Jason Hoitt
Chief Patient Officer
Katherine Pare Lefeber
Vice President, Strategy
Malini Viswanathan Ph.D
Vice President Portfolio and Alliance Management
Jessica Blumstein
Vice President, Global Market Access And Distribution
Isabel Aznarez
Co-Founder & VP, Discovery Research
Anne Christiansen
Executive Director
Tommy Leggett
Chief Financial Officer
Beth Mellen
Chief Regulatory Officer
Naomi Muse
Svp, Program Leadership & Management
Stephen Yu
VP Head of IT

Board & advisors

Adrian Krainer
Co-Founder & Director
Arthur Levin
Director